
We report the case of a 72-year-old man who underwent cardiac surgery for Group B Streptococcus infective endocarditis with embolic hepatic abscesses. Severe postoperative vasoplegia was treated with repeated methylene blue boluses and infusions while on central veno-arterial extracorporeal membrane oxygenation (V-A ECMO) for refractory cardiogenic and vasoplegic shock. Following multiple methylene blue administrations, the ECMO return tubing appeared dark, raising concern for membrane lung dysfunction (MLD). However, post-membrane lung blood gases confirmed adequate oxygen exchange and visual inspection on the post-membrane lung side of the circuit revealed bright red blood within the membrane lung (ML) and all rigid connectors. The discoloration was determined to have resulted from methylene blue staining of the flexible PVC tubing which mimicked the appearance of the post-ML flexible PVC tubing in a failed membrane lung despite the oxygenator functioning appropriately. Awareness of this artifact is critical to avoid unnecessary interventions; evaluation of post-ML blood gases and visual comparison with unstained ECMO circuit components can distinguish this benign finding from true MLD.
Introduction Venovenous extracorporeal membrane oxygenation is established support for severe acute respiratory distress syndrome with refractory respiratory failure, but some patients also have circulatory failure and receive cardiac or cardiorespiratory extracorporeal life support. Mortality in this group is poorly defined. Methods We conducted a systematic review and random-effects meta-analysis of observed hospital and intensive care unit mortality according to the initial extracorporeal life support configuration, with certainty of evidence assessed using GRADE. Odds ratios are expressed for respiratory support relative to cardiac or cardiorespiratory support, so that a value below 1 indicates lower mortality with respiratory support alone. Results Twelve observational studies contributed data from 5,875 patients. Hospital mortality was lower with respiratory support (9 studies; odds ratio 0.59, 95% confidence interval 0.37–0.92; I 2 = 62.5%; 95% prediction interval 0.21–1.60; low-certainty evidence), as was intensive care unit mortality (5 studies; odds ratio 0.40, 95% confidence interval 0.23–0.69; very-low-certainty evidence). The cohorts were clinically heterogeneous and rarely adjusted for shock severity, vasoactive support, lactate, cardiac function or general severity scores. Conclusions Because the configuration was selected in response to haemodynamic compromise and may also reflect centre practice, these pooled estimates describe an association and not the effect of an extracorporeal support strategy. Higher observed mortality in patients receiving cardiac or cardiorespiratory support is likely to be explained in large part by greater baseline illness severity and residual confounding.
Background and aims Mortality from heart failure is still high despite all the recent advances. Continuous-flow (CF) Veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO) can temporarily maintain systemic and pulmonary hemodynamics, at the cost of overloading the left ventricle (LV). A new Pulsatile Ventricular Assist Platform (pVAP) could offer a more physiological hemodynamic support. Methods 6 large porcine models of acute ischemic left ventricular (LV) failure received the pVAP in a VA-ECMO configuration. Invasive systemic and intraventricular hemodynamic measurements were taken with synchronized counter-pulsatile flow (SCPF) and CF support at the same flow rate. The measurements were compared with no support (ON vs OFF) in both modalities. Results The pVAP successfully delivered VA-ECMO in acute ischemic heart failure. The device maintained stable hemodynamics and increased the forward cardiac output (CO F ) without overloading the LV and with no change in the LV pressure-volume area (PVA). SCPF, but not CF, was associated with improved LV afterload and ventricular-arterial coupling compared to no support. Conclusion The findings suggest that the pVAP is feasible also in a VA-ECMO configuration, supporting hemodynamics with more physiological effect on effect on the LV dynamics.
Congenital syphilis (CS) is a severe infection with a rising global incidence and potentially life-threatening neonatal outcomes. We present a late preterm infant exhibiting respiratory distress, hepatosplenomegaly, and systemic inflammation. Diagnosed with congenital syphilis at 12 hours of life, targeted antimicrobial was promptly initiated. Despite maximal medical management, her clinical course rapidly deteriorated into refractory shock, severe pulmonary hypertension, and multiple organ dysfunction. This necessitated venoarterial extracorporeal membrane oxygenation (VA-ECMO). The infant underwent 7 days of VA-ECMO, 19 days of renal replacement therapy and 23 days of mechanical ventilation before successfully discharging with multidisciplinary follow-up. This case underscores the devastating potential of re-emerging congenital syphilis. It also highlights VA-ECMO as a viable rescue therapy for refractory neonatal shock, emphasizing the critical need for early referral to specialized centers.